Ksenia Loskutva

Ms. Ksenia Loskutva

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2019 in BioMed Research International
Verified
Journal Article
Open access
KLKsenia Loskutva
Ksenia Loskutva
DGDmitry Grishenkov
Dmitry Grishenkov
Morteza GhorbaniMorteza Ghorbani
Morteza Ghorbani
Acoustic droplet vaporization (ADV) is the physical process in which liquid undergoes phase transition to gas after exposure to a pressure amplitude above a certain threshold. In recent years, new techniques in ultrasound diagnostics and therapeutics have been developed which utilize microformulations with various physical and chemical properties. The purpose of this review is to give the reader a general idea on how ADV can be implemented for the existing biomedical applications of droplet vaporization. In this regard, the recent developments in ultrasound therapy which shed light on the ADV are considered. Modern designs of capsules and nanodroplets (NDs) are shown, and the material choices and their implications for function are discussed. The influence of the physical properties of the induced acoustic field, the surrounding medium, and thermophysical effects on the vaporization are presented. Lastly, current challenges and potential future applications towards the implementation of the therapeutic droplets are discussed.

24 September 2019 in Langmuir
Verified
Journal Article
Closed access
MGMorteza Ghorbani
Morteza Ghorbani
KOKarl Olofsson
Karl Olofsson
JBJan-Willem Benjamins
Jan-Willem Benjamins
KLKsenia Loskutva
Ksenia Loskutva
TPThomas Paulraj
Thomas Paulraj
ASAnna J. Svagan
Anna J. Svagan

1 April 2023 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
KLKsenia Loskutva
Ksenia Loskutva
MTMar Torras
Mar Torras
YZYing Zhao
Ying Zhao
ASAnna J Svagan
Anna J Svagan
DGDmitry Grishenkov
Dmitry Grishenkov
Purpose: To study the effect of cellulose nanofiber (CNF)-shelled perfluoropentane (PFP) droplets on the cell viability of 4T1 breast cancer cells with or without the addition of non-encapsulated paclitaxel. Methods: The CNF-shelled PFP droplets were produced by mixing a CNF suspension and PFP using a homogenizer. The volume size distribution and concentration of CNF-shelled PFP droplets were estimated from images taken with an optical microscope and analyzed using Fiji software and an in-house Matlab script. The thermal stability was qualitatively assessed by comparing the size distribution and concentration of CNF-shelled PFP droplets at room temperature (~22°) and 37°C. The cell viability of 4T1 cells was measured using a 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Additionally, a hemolysis assay was performed to assess blood compatibility of CNF-shelled PFP droplets. Results: The droplet diameter and concentration of CNF-shelled PFP droplets decreased after 48 hours at both room temperature and 37°C. In addition, the decrease in concentration was more significant at 37°C, from 3.50 ± 0.64× 106 droplets/mL to 1.94 ± 0.10× 106 droplets/mL, than at room temperature, from 3.65 ± 0.29× 106 droplets/mL to 2.56 ± 0.22× 106 droplets/mL. The 4T1 cell viability decreased with increased exposure time and concentration of paclitaxel, but it was not affected by the presence of CNF-shelled PFP droplets. No hemolysis was observed at any concentration of CNF-shelled PFP droplets. Conclusion: CNF-shelled PFP droplets have the potential to be applied as drug carriers in ultrasound-mediated therapy.

27 November 2020 in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Verified
Journal Article
Closed access
HCHongjian Chen
Hongjian Chen
DEDimitrios Evangelou
Dimitrios Evangelou
KLKsenia Loskutva
Ksenia Loskutva
Morteza GhorbaniMorteza Ghorbani
Morteza Ghorbani
DGDmitry Grishenkov
Dmitry Grishenkov
Contrast agents are routinely used in ultrasound examinations. Nonlinear ultrasound imaging techniques have been developed over decades to enhance the contrast between the tissue and the blood pool after the injection of ultrasound contrast agents. In this study, we introduce a new contrast pulse sequence, CPS4. The CPS4 combines pulse inversion, sub-harmonic, and ultra-harmonic techniques to remove propagation distortion while capturing the unique sub-harmonic, and ultra-harmonic responses from ultrasound contrast agents. The novel CPS4 and conventional pulse inversion, sub-harmonic, and ultra-harmonic techniques were used to detect the presence of a research-grade, thick shell, polymer microbubble in a tissue-mimicking flow phantom. The contrast-to-tissue ratio (CTR) obtained from the applications of all techniques were compared. The results show that the highest CTR of approximately 16 dB was obtained using CPS4, which was superior to the individual reference techniques: pulse inversion, sub-harmonic, and ultra-harmonic techniques, at all scenarios considered in this study.

17 February 2021 in ACS Omega
Verified
Journal Article
Open access
KLKsenia Loskutva
Ksenia Loskutva
DNDidrik Nimander
Didrik Nimander
IGIsabelle Gouwy
Isabelle Gouwy
HCHongjian Chen
Hongjian Chen
Morteza GhorbaniMorteza Ghorbani
Morteza Ghorbani
DGDmitry Grishenkov
Dmitry Grishenkov
Acoustic droplet vaporization (ADV) is the physical process of liquid-to-gas phase transition mediated by pressure variations in an ultrasound field. In this study, the acoustic response of novel particle-stabilized perfluoropentane droplets was studied in bulk and confined media. The oil/water interface was stabilized by cellulose nanofibers. First, their acoustic responses under idealized conditions were examined to assess their susceptibility to undergo ADV. Second, the droplets were studied in a more realistic setting and placed in a confined medium. Lastly, an imaging setup was developed and tested on the droplets. The acoustic response could be seen when the amplitude of the peak negative pressure (PNP) was above 200 kPa, suggesting that this is the vaporization pressure threshold for these droplets. Increasing the PNP resulted in a decrease in signal intensity over time, suggesting a more destructive behavior. The imaging setup was able to differentiate between the droplets and the surrounding tissue. Results obtained within this study suggest that these droplets have potential in terms of ultrasound-mediated diagnostics and therapy.

27 November 2021 in Micromachines
Verified
Journal Article
Open access
PDF file
KLKsenia Loskutva
Ksenia Loskutva
KOKarl Olofsson
Karl Olofsson
BHBjörn Hammarström
Björn Hammarström
Martin WiklundMartin Wiklund
Martin Wiklund
ASAnna J. Svagan
Anna J. Svagan
DGDmitry Grishenkov
Dmitry Grishenkov
Droplets with a liquid perfluoropentane core and a cellulose nanofiber shell have the potential to be used as drug carriers in ultrasound-mediated drug delivery. However, it is necessary to understand their mechanical properties to develop ultrasound imaging sequences that enable in vivo imaging of the vaporization process to ensure optimized drug delivery. In this work, the compressibility of droplets stabilized with cellulose nanofibers was estimated using acoustophoresis at three different acoustic pressures. Polyamide particles of known size and material properties were used for calibration. The droplet compressibility was then used to estimate the cellulose nanofiber bulk modulus and compare it to experimentally determined values. The results showed that the acoustic contrast factor for these droplets was negative, as the droplets relocated to pressure antinodes during ultrasonic actuation. The droplet compressibility was 6.6–6.8 ×10−10 Pa−1, which is higher than for water (4.4×10−10 Pa−1) but lower than for pure perfluoropentane (2.7×10−9 Pa−1). The compressibility was constant across different droplet diameters, which was consistent with the idea that the shell thickness depends on the droplet size, rather than being constant.